Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1460-1467

  Dettenhofer, Markus ^a   Yu, Xiao Fang ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GENE PRODUCT; VIF PROTEIN;

ANIMAL CELL; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VIRION; VIRUS ASSEMBLY; VIRUS INFECTIVITY; VIRUS PARTICLE;

EID: 0032935035     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1460-1467.1999     Document Type: Article

References (65)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Aiken, C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:5871-5877.
3. Arthur, L. O., J. W. Bess, Jr., R. C. D. Sowder, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
4. Berthoux, L., C. Pechoux, M. Ottmann, G. Morel, and J. L. Darlix. 1997. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J. Virol. 71:6973-6981.
5. Bess, J. W., Jr., R. J. Gorelick, W. J. Bosche, L. E. Henderson, and L. O. Arthur. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230:134-144.
6. - mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69: 2058-2067.
7. Gag precursor. J. Virol. 71:9358-9365.
8. Bouyac, M., F. Rey, M. Nascimbeni, M. Courcoul, J. Sire, D. Blanc, F. Clavel, R. Vigne, and B. Spire. 1997. Phenotypically Vif human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71:2473-2477.
9. Bratten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-3560.
10. Camaur, D., and D. Trono. 1996. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:6106-6111.
11. Cohen, E. A., G. Dehni, J. G. Sodroski, and W. A. Haselline. 1990. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:3097-3099.
12. Cosson, P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:5783-5788.
13. Courcoul, M., C. Patience, F. Rey, D. Blanc, A. Harmache, J. Sire, R. Vigne, and B. Spire. 1995. Peripheral blood mononuclear cells produce normal amounts of defective Vif human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
14. Dorfman, T., F. Mammano, W. A. Haseltine, and H. G. Gottlinger. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696.
15. Dubay, J. W., S. J. Roberts, B. H. Hahn, and E. Hunter. 1992. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66:6616-6625.
16. Fan, L., and K, Peden. 1992. Cell-free transmission of Vif mutants of HIV-1. Virology 190:19-29.
17. Fisher, A. G., B. Ensoli, L. Ivanoff, M. Chamberlain. S. Petteway, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893.
18. Fouchier, R. A., J. H. Simon, A. B. Jaffe, and M. H. Malim. 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70:8263-8269.
19. Franke, E. K., H. E. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
20. Freed, E. O., and M. A. Martin. 1996. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:341-351.
21. + T lymphocytes. J. Virol. 66:6489-6495.
22. Gamble, T. R., F. F. Vajdos, S. Yoo, D. K. Worthylake, M. Houseweart, W. I. Sundquist, and C. P. Hill, 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-1294.
23. Garcia, J. V., and A. D. Miller. 1991. Serine phosphorylation-indcpendent downregulation of cell-surface CD4 by nef. Nature 350:508-511.
24. Gluschankof, P., I. Mondor, H. R. Gelderblom, and Q. J. Sattentau. 1997. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 230:125-133.
25. Goh, W. C., M. E. Rogel, C. M. Kinsey, S. F. Michael, P. N. Fultz, M, A. Nowak, B. H. Hahn, and M. Emerman. 1998. HIV-1 Vpr increases viral expression hy manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 4:65-71.
26. Goncalves, J., Y. Korin. J. Zack, and D. Gabuzda. 1996. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:87(11-8709.
27. Goncalves, J., B. Shi, X. Yang, and D. Gabuzda. 1995. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J. Virol. 69:7196-7204.
28. Graham, J., T. Ford, and D. Rickwood. 1994. The preparation of subcellular organelles from mouse liver in self-generated gradients of iodixanol. Anal. Biochem. 220:367-373.
29. Hoglund, S., A. Ohagen, K. Lawrence, and D. Gabuzda. 1994. Role of vif during packing of the core of HIV-1. Virology 201:349-355.
30. Hunter, E. 1994. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:71-83.
31. Kan, N. C., G. Franchini, F. Wong-Staal, G. C. DuBois, W. G. Robey, J. A. Lautenberger, and T. S. Papas. 1986. Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera. Science 231:1553-1555.
32. Karczewski, M. K., and K. Strebel. 1996. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:494-507.
33. Kondo, E., F. Mammano, E. A. Cohen, and H. G. Gottlinger. 1995. The p6gag domain of human immunodeficiency virus type I is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69:2759-2764.
34. Lee, T. H., J. E. Coligan, J. S. Allan, M. F. McLane, J. E. Groopman, and M. Essex. 1986. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546-1549.
35. + T cells. Virology 243:718-93.
36. Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69: 7630-7638.
37. poration into human immunodeficiency virus type I particles. J. Virol. 69: 6873-6879.
38. Lu, Y. L., P. Spearman, and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67: 6542-6550.
39. Luban, J., K. L. Bossolt, E. K. Franke, G. V. Kalpana. and S. P. Goff. 1993 Human immunodeficiency virus type 1 Gag protein hinds to cyclophilins A and B. Cell 73:1067-1078.
40. Luciw, P. A. 1996. Human immunodeficiency viruses and their replication, p. 1881-1952. In B. N. Fields, D. M. Knipe. P. M. Howley. et al. (ed.). Virology. Lippincott-Raven, Philadelphia, Pa.
41. Ochsenbauer, C., T. Wilk, and V. Bosch. 1997. Analysis of vif-defcctive human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'nonpermissive' T lymphoid cells stably infected with selectable HIV-1. J. Gen. Virol. 78:627-635.
42. Ott, D. E., L. V. Coren, D. G. Johnson, R. C. N. Sowder, L. O. Arthur, and L. E. Henderson. 1995. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res. Hum. Retroviruses 11:1003-1006.
43. Ott, D. E., L. V. Coren, B. P. Kane, L. K. Busch, D. G. Johnson, R. C. N. Sowder, E. N. Chertova, L. O. Arthur, and L. E. Henderson. 1996. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70:7734-7743.
44. Pandori, M. W., N. J. Fitch, H. M. Craig, D. D. Richman, C. A. Spina, and J. C. Guatelli. 1996. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70:4283-4290.
45. Paxton, W., R. I. Connor, and N. R. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type I virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67:7229-7237.
46. Popov, S., M. Rexach, G. Zybarth, N. Reiling. M. A. Lee, L. Ratner, C. M. Lane. M. S. Moore, G. Blobel, and M. Bukrinsky. 1998. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17:909-917.
47. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. . Whitehorn, K. Baumeister, et al. 1985 Complete nucleotide sequence of the AIDS virus. HTLV-III. Nature 313: 277-284.
48. Rey, O., J. Canon, and P. Krogstad. 1996. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology 220:530-534.
49. Richieri, S. P., R. Bartholomew, R. C. Aloia, J. Savary, R. Gore, J. Holt, F. Ferre, R. Musil, H. R. Tian, R. Trauger, P. Lowry, F. Jensen, D. J. Carlo, R. Z. Maigetter, and C. P. Prior. 1998. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine 16:119-129.
50. Sakai, H., R. Shibata, J. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1666.
51. Simm. M., M. Shahabuddin, W. Chao, J. S. Allan, and D. J. Volsky. 1995. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J. Virol. 69:4582-4586.
52. Simon, J. H., R. A. Fouchier, T. E. Southerling, C. B. Guerra. C. K. Grant, and M. H. Malim. 1997. The Vif and Gag proteins of human immunodefi-ciency virus type 1 colocalize in infected human T cells. J. Virol. 71:5259-5267.
53. Simon. J. H., and M. H. Malim. 1996. The human immunodeficiency virus type I Vif protein modulates the postpenctration stability of viral nucleoprotein complexes. J. Virol. 70:5297-5305.
54. Sodroski, J., W. C. Goh, C. Rosen, A. Tartar, D. Portetelle, A. Burny, and W. Haseltine. 1986. Replicative and cytopathic potential of HTL V-III/LAV with sor gene deletions. Science 231:1549-1553.
55. Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
56. Thali, M., A. Bukovs. E. Kondo, B. Rosenwirth, C. T. Walsh, J. Sodroski, and H. G. Gottlinger. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365.
57. Vodieka, M. A., D. M. Koepp, P. A. Silver, and M. Emerman. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:175-185.
58. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:49451955.
59. Welker, R., H. Kottler, H. R. Kalbitzer, and H. G. Krausslich. 1996. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral protease. Virology 219:228-236.
60. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral gag proteins (editorial). AIDS 5:639-654.
61. Yu, X., X. Yuan, Z. Matsuda, T. H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type I is required for incorpora-tion of viral envelope protein into mature virions. J. Virol. 66:4966-4971.
62. Yu, X., X. Yuan, M. F. McLane, T. H. Lee, and M. Essex. 1993. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmcm-brane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67:213-221.
63. Yu, X. F., M. Matsuda, M. Essex, and T. H. Lee. 1990. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J Virol. 64:5688-5693.
64. Yu, X. F., Z. Matsuda, Q. C. Yu, T. H. Lee, and M. Essex. 1995. Role of the C terminus Gag protein in human immunodeticiency virus type 1 virion assembly and maturation. J. Gen. Virol. 76:3171-3179.
65. Yuan, X., Z. Matsuda, M. Matsuda, M. Essex, and T. H. Lee. 1990. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses 6:1265-1271.